Melanoma Research Reagents | BRAF, PD-1, CTLA-4 Antibodies

Home > Featured Products > Oncology Research > Melanoma

960 product results for "Melanoma"

Options+

Options

Confirm

Product types

0 selected

Antibodies (298)

Stable Cell Lines (1)

Biosimilars (1)

Assay Kit (419)

Proteins (75)

Research Biosimilar (157)
Expression system

0 selected

HEK293T (1)

Mammalian Cells (185)

E. coli (35)
Target

0 selected

Amatuximab (1)

CD274/PD-L1 & VEGFA (1)

NP/Nucleocapsid (5)

dsDNA (1)

Belantamab (1)

Tiragolumab (2)

Obiltoxaximab (1)

CD19 & PD-L1 & CD3E & CD137 (1)

FLT1/VEGFR1 & CD274/PD-L1 (1)

RBD (E484K) (1)

Nivolumab (3)

Atezolizumab (3)

Sotrovimab (1)

Retatrutide (1)

gD/Envelope glycoprotein D (1)

Utomilumab (1)

A29L (6)

EGFR & CD3E & PD-L1 & 4-1BB (1)

B6R/SL-159 (1)

Pogalizumab (1)

Bimekizumab (1)

Guselkumab (3)

Ipilimumab (2)

CD274/PD-L1 & CD47/MER6 (1)

gp100 peptide-HLA Complex (1)

Golimumab (3)

CD47/MER6 & CD274/PD-L1/B7-H1 (2)

CD223/LAG3 (41)

CD152/CTLA4 & CD134/OX40 (1)

Lupartumab (1)

Pertuzumab (3)

TFF3 (1)

Anifrolumab (1)

Camidanlumab (1)

Varisacumab (1)

Tesidolumab (1)

BSA (1)

Sirukumab (1)

VEGFA & B7-H1 / PD-L1 / CD274 (1)

BRAF/B-Raf (5)

TYR (1)

Abatacept (1)

Lexatumumab (1)

dsRNA (1)

RBD (Omicron/BA.4/BA.5) (1)

Cusatuzumab (1)

Anetumab (1)

Blosozumab (1)

CD274/PD-L1 & TGFBR2/TGFR-2 (1)

Varlilumab (1)

Glycoprotein (5)

Teclistamab (1)

Sarilumab (2)

RBD (Kappa) (1)

Ascrinvacumab (1)

Pembrolizumab (3)

Avelumab (3)

CD152/CTLA4 (86)

Casirivimab (1)

Daratumumab (3)

β-D-Glucan (1)

gC/Envelope glycoprotein C (1)

Tezepelumab (1)

IL6 (1)

SARS-CoV-2 Neutralization Antibody (3)

Tavolimab (1)

TIGIT & CD274/PD-L1 (1)

Ixekizumab (1)

Suvizumab (1)

ATP7B (1)

S100A14 (1)

Lenzilumab (1)

Semorinemab (1)

Tremelimumab (1)

CD274/PD-L1 & CD134/OX40 (1)

T3E (1)

S100A5 (4)

Cixutumumab (1)

Andecaliximab (1)

Vofatamab (1)

Trastuzumab (2)

PD-L1 & TGF-Beta (1)

Obinutuzumab (2)

PD-L1 / VEGF-A (1)

Daclizumab (1)

Emibetuzumab (1)

Protein A (1)

Ziltivekimab (1)

Carlumab (1)

Indatuximab (1)

Tigatuzumab (1)

Vorsetuzumab (1)

DCT (2)

Romosozumab (1)

CD274/PD-L1 & CD137/TNFRSF9 (1)

Romiplostim (2)

M/Matrix protein (2)

Rituximab (1)

Enoblituzumab (1)

TYRP1 (3)

Gremubamab (1)

RBD (Delta Plus) (1)

Sintilimab (1)

Durvalumab (3)

Imdevimab (1)

S100A4 (3)

gC/UL44 (1)

Magrolimab (1)

RBD (Omicron/BA.5) (3)

Lirilumab (1)

Remtolumab (1)

S100A10 (4)

TPP15 (1)

Namilumab (1)

Tilavonemab (1)

CTLA4 & PD1 (2)

Zalifrelimab (1)

T-cell surface antigen T3/Leu-4 epsilon chain (1)

Infliximab (2)

Dalotuzumab (1)

Depatuxizumab (1)

CD137/4-1BB/TNFRSF9& CD274/PD-L1/B7-H1 (1)

Zanidatamab (1)

Afutuzumab (1)

Icrucumab (1)

CD366/HAVCR2/TIM-3 (4)

PDL1 (6)

Crizanlizumab (1)

TRP-1 & CD3e (1)

Tanezumab (1)

Human β Amyloid (1-42) (1)

S100A6 (1)

LAG-3 & PD-1 (1)

Secukinumab (2)

Foravirumab (1)

Elotuzumab (1)

Ontamalimab (1)

Eculizumab (3)

Talacotuzumab (1)

Tirzepatide (2)

Pasotuxizumab (1)

Mirzotamab (1)

M1R (5)

Semaglutide (2)

Cinpanemab (1)

Tislelizumab (1)

Pacmilimab (1)

CD274/PD-L1 & CD152/CTLA4 (1)

CD223/LAG3 & CD279/PD-1 (4)

Ifabotuzumab (1)

Siltuximab (3)

gD/US6 (1)

Elezanumab (1)

Etanercept (3)

NP/Nucleoprotein (3)

CD20/MS4A1 (3)

CD47/MER6 & PDCD1 / PD-1 / CD279 (1)

Lorvotuzumab (1)

Lintuzumab (1)

TPP17 (1)

Otilimab (1)

Zagotenemab (1)

IDO1 (2)

CD274/PD-L1 & CD28 (1)

T-cell surface glycoprotein CD3 epsilon chain (1)

Figitumumab (1)

Farletuzumab (1)

S100A1 (2)

SOX10 (3)

S100A12 (1)

Oxelumab (1)

Losatuxizumab (1)

Spike glycoprotein (RBD) (1)

CD274/PD-L1 & CD28 & CD152/CTLA4 (1)

Epcoritamab (1)

Fluorescein & CD274/PD-L1 (1)

Ibalizumab (1)

S100a15a (1)

Tocilizumab (3)

Inclacumab (1)

S100P (1)

Human β Amyloid (1-40) (1)

Cergutuzumab (1)

KITLG/SCF (1)

Codrituzumab (1)

Mazdutide (2)

NRAS (2)

Rafivirumab (1)

RBD (WT) (1)

CD274/PD-L1 & TGFBR2 (1)

Meplazumab (1)

Mirikizumab (2)

Aflibercept (1)

Vibecotamab (1)

Glycoprotein G (2)

GP/Envelope glycoprotein (4)

Rosopatamab (2)

TYR/Tyrosinase (2)

Omburtamab (1)

Evolocumab (1)

CD366/TIM-3 & CD274/PD-L1 (1)

Toripalimab (1)

CD279/PD-1 & CD152/CTLA4 (4)

Denosumab (3)

US8/gE (1)

Sibrotuzumab (1)

HLA-A2-peptide (TDQVPFSV) Complex (1)

RBD (6)

RBD (Omicron/JN.1) (1)

TAU pT181 (1)

Labetuzumab (1)

B7-H1 / PD-L1 / CD274 & CD3E (1)

Faricimab (1)

TPP47 (1)

TDP2 (1)

Asp f 1/mitF (1)

MITF (1)

CD223 (1)

Edrecolomab (1)

S100A11 (2)

S100A16 (1)

Canakinumab (1)

MLANA (4)

Ganitumab (1)

Mirvetuximab (1)

Necitumumab (1)

Zenocutuzumab (1)

CD274/PD-L1/B7-H1 (5)

Glofitamab (1)

Ieramilimab (1)

S100A13 (1)

Tregalizumab (1)

TRP-1 & CD47/MER6 (1)

Adalimumab (3)

S100A2 (1)

Dupilumab (3)

RBD (Omicron/KP.2) (1)

Tibulizumab (1)

HLA-A2-peptide (ITDQVPFSV) Complex (4)

RBD (Alpha) (1)

p-Tyr (1)

Glembatumumab (1)

gG/US4 (2)

PMEL17/ME20M (9)

Tarextumab (1)

H3L (3)

Alirocumab (1)

CD137/4-1BB & CD274/PD-L1 (3)

CD79B (2)

S100A8 (3)

Nirsevimab (1)

CD223/LAG3 & CD152/CTLA4 (1)

Cetuximab (3)

Letolizumab (1)

Imlifidase (5)

Spike glycoprotein E2 (2)

Enfortumab (1)

RBD (Delta) (3)

TAU pT217 (1)

Tisotumab (1)

Oleclumab (1)

Nesvacumab (1)

G/Major surface glycoprotein G (1)

Milatuzumab (1)

Befovacimab (1)

VSIR/VISTA & CD274/PD-L1 (1)

Gevokizumab (1)

Teprotumumab (1)

VASH2/Vasohibin-2 (1)

Bevacizumab (3)

Panitumumab (3)

EPO/Erythropoietin (1)

cAMP (1)

Ibritumomab (1)

Benufutamab (1)

Zanolimumab (1)

Lacnotuzumab (1)

Olaratumab (1)

TRP-1 & CD134/OX40 (1)

Spike glycoprotein (10)

CD340/ERBB2 (1)

Astegolimab (1)

LAG3 & PD-1 (1)

Vunakizumab (1)

HLA-A2-peptide (YLEPGPVT) Complex (4)

Tosatoxumab (1)

CD152/CTLA4 & CD279/PD-1 (1)

RBD (Beta) (1)

CD137/4-1BB & CD274/PD-L1 & ROR1 & CD3 (1)

Alacizumab (1)

Balstilimab (1)

Dilpacimab (1)

Natalizumab (2)

Exenatide acetate (2)

gB/Envelope glycoprotein B (1)

Omalizumab (2)

Frovocimab (1)

E8L (5)

CD274/PD-L1 & CD279/PD-1 (1)

Palivizumab (3)

CD47/MER6 & CD274/PD-L1 (2)

sCD14 (1)

Simlukafusp Alfa (1)

CD279/PD-1 & CD274/PD-L1 (1)

Certolizumab (2)

Calprotectin (S100A8/9) (3)

Cabiralizumab (1)

CD47/MER6 & PDCD1 / PD-1 & CD137/4-1BB/TNFRSF9 (1)

CD152/CTLA4 & CD274/PD-L1 (1)

Vanucizumab (1)

N/Nucleoprotein (1)

PD-L1 & VEGF (1)

Concizumab (1)

Rolinsatamab (1)

CD278/ICOS (1)

Brolucizumab (1)

Serclutamab (1)

S100B (9)

Clazakizumab (1)

S100A9 (4)

Mosunetuzumab (1)

Mavezelimab (1)

CD80/B7-1 (20)

Conatumumab (1)

Tovetumab (1)

Ianalumab (1)

CD274/PD-L1 & SLT-Ia (1)

Spike Protein (Trimer) (2)

Iscalimab (1)

IL1RL1/ST2 (1)

mitF/aspF1 (1)

HLA-A2-peptide (KTWGQYWQV) Complex (2)

RBD (Gamma) (1)

Ramucirumab (1)

Cetrelimab (1)

Navicixizumab (1)

Bimagrumab (1)

gE/Envelope glycoprotein E (1)

CD175/Tn (10)

Urelumab (1)

Lodelcizumab (1)

A35R (5)

CD366/TIM-3 & CD279/PD-1 (2)

Ustekinumab (3)

Ivuxolimab (1)

Afasevikumab (1)

Suptavumab (1)

F/Fusion glycoprotein F0 (5)

Itolizumab (1)

PDL1 & VEGF (1)

CD274/PD-L1 & CD3E (1)

CD3E (1)

Emactuzumab (1)

Imalumab (1)

Zampilimab (1)

CD80&IL2 (1)

Disitamab (1)

Marstacimab (1)

CD80/B7-1 & CD86/B7-2 (2)

Basiliximab (1)

Apamistamab (1)

CD117/KIT (24)

Ranibizumab (3)

CD274/PD-L1 (81)

CD366/TIM-3 (34)

cGMP (1)

Olokizumab (1)

Ocaratuzumab (1)

Favezelimab (1)

CD86/B7-2 (26)

Drozitumab (1)

Spike glycoprotein E1 (2)

Eldelumab (1)

Sacituzumab (1)
Species

0 selected

Canis lupus familiaris (1)

Felis catus (Cat) (9)

Cat (1)

Mouse (24)

Rat (1)

Mus musculus (Mouse) (7)

Tupaia chinensis (12)

Homo sapiens (Human) (7)

Canis lupus familiaris (Dog) (8)

Neosartorya fumigata (1)

Human (177)

Dog (3)
Applications

0 selected

in vivo CTLA-4 neutralization (2)

Bioactivity: FACS (1)

Research in vivo (4)

in vivo intra-tumoral regulatory T cell depletion (2)

FCM (152)

in vivo (2)

Bioactivity: FACS (153)

in vivo blockade (2)

Blocking (2)

SDS-PAGE (75)

Functional assay (158)

IP (2)

SPR (4)

Immunogen (75)

in vivo PD-L1 blockade (3)

FuncS (18)

Research in vivo (158)

Bioactivity testing in progress (31)

in vitro PD-L1 blockade (3)

ELISA (844)

Neut (1)

IFA (4)

GICA (2)

IHC-F (3)

IHC (84)

Inhib (1)

FACS (5)

WB (165)

Neutralization (2)

Functional assay (6)

IF (8)
Reactivity

0 selected

Kirsten murine sarcoma virus (1)

Cat (1)

Dog (13)

Chicken (4)

Homo sapiens (Human) (4)

Mouse (81)

Kryptolebias marmoratus (1)

Pig (6)

Macaca mulatta (1)

Carassius auratus (1)

Pongo abelii (2)

Human (199)

Rat (16)

Tupaia chinensis (4)

Limanda limanda (1)

Neosartorya fumigata (1)

Cavia porcellus (1)

Bos taurus (8)

Mesocricetus auratus (1)

Broad-Spectrum (1)

Monkey (5)

Cyprinus carpio (1)

Oryctolagus cuniculus (4)

Monodelphis domestica (1)

B7-H1 / PD-L1 / CD274 (1)

Danio rerio (1)

Callithrix jacchus (1)

Avian retrovirus IC10 (1)

Oryzias latipes (1)

Drosophila grimshawi (1)

Capra hircus (1)

Avian rous-associated virus type 1 (1)

Cynomolgus monkey (1)

Xenopus laevis (1)

Mus musculus (Mouse) (1)

Drosophila willistoni (1)

Coturnix japonica (1)

Rhesus macaque (1)

Bovine (1)
Host species

0 selected

Chimeric (5)

Rabbit (61)

Alpaca (6)

HEK293T (1)

Human (157)

Armenian Hamster (5)

Rat (14)

Humanized (34)

Dog (2)

Mouse (164)
Clonality

0 selected

Monoclonal (398)

Polyclonal (53)
Conjugate

0 selected

PerCP (28)

PE (28)

Unconjugated (301)

FITC (28)

APC (28)

Recombinant Proteins

Antibodies

Assay Kits

960 product results for "Melanoma"

Imdevimab ELISA kit (DK565038)

Sample type

Range

Romiplostim ELISA Kit (YB762018)

Sample type

Sensitivity

Range

Monkeypox Virus (MPXV) B6R Antigen ELISA Kit (VK526018)

Sample type

Sensitivity

Range

SARS-CoV-2 RBD (JN.1) ELISA Kit (VK565048)

Sample type

Sensitivity

Range

Tirzepatide (LY3298176) ELISA Kit (DP899028)

Sample type

Range

Anti-Semaglutide ELISA Kit (AP899018)

Sample type

Sensitivity

Range

Anti-Tocilizumab ELISA Kit (AY583018)

Sample type

Range

Rosopatamab ELISA Kit (DC669028)

Sample type

Sensitivity

Range

Urelumab ELISA Kit (DC336018)

Sample type

Sensitivity

Range

Magrolimab ELISA Kit (DC359018)

Sample type

Sensitivity

Range

Quick access

Contact Us